Spots Global Cancer Trial Database for Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
Official Title: Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology
Study ID: NCT04264975
Conditions
Interventions
Study Description
Brief Summary: This is an open label, single-center, non-randomized clinical trial on utilization of microbiome as biomarkers and therapeutics in immuno-oncology. This research consists of two parts: part 1: development of microbiome biomarkers for immuno-oncology part 2: proof-of-concept trial on the fecal microbiota transplantation in patients who are being treated with immunotherapy for advanced solid tumor
Detailed Description:
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Asan Medical Center, Seoul, , Korea, Republic of
Contact Details
Name: Sook Ryun Park, M.D, Ph D
Affiliation: Asan Medical Center, Ulsan University of College of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
